Somatic/Embodied Interface (HEART-SE) Division
What it protects
The human body is not a peripheral device. It’s the substrate through which a person exists, acts, perceives, and maintains coherent selfhood. When AI systems interface with the body through wearables, brain-computer interfaces, adaptive prosthetics, implantable medical devices, haptic systems, or physiologically integrated spatial computing, they intervene in the biological infrastructure of personhood itself.
The harm signature of somatic AI is distinct from every other HEART division because consequences are physical, immediate, and potentially irreversible. An attention-capture system can be uninstalled. Epistemic degradation can be reversed. A somatic AI system that sends an incorrect signal to a neural implant, miscalibrates a prosthetic during a critical movement, or delivers a wrong dosage through an adaptive drug delivery system produces harm that exists in flesh. The body has no undo function.
HEART-SE identifies six components of biological infrastructure that certification protects:
| Infrastructure | What it enables |
|---|---|
| Autonomic regulation | Stable control of heart rate, respiration, and hormonal balance without device-driven interference |
| Neural signaling integrity | Accurate read/write access to neural patterns without adaptive drift or optimization-driven distortion |
| Motor control and body schema | Coherent proprioception and movement patterns, including AI-augmented prosthetic function |
| Sensory processing | Accurate perception of physical reality without haptic or spatial-computing-induced sensory training |
| Physiological homeostasis | Safe operating ranges maintained by adaptive medical devices without compound loop risk |
| Somatic autonomy | The user’s preferences, not the device manufacturer’s optimization targets, govern adaptive behavior |
A further structural concern: AI systems interfacing with the body gain access to a feedback loop with no precedent in human history. A cardiac device adapting its rhythm management based on the patient’s own signals is shaping the patterns it interprets. A haptic system learning touch preferences is training the user’s sensory expectations. This coupling creates dependency that market incentives won’t self-correct. A person whose prosthetic has co-adapted with their neural patterns and muscle memory cannot simply switch providers. The switching costs are somatic, not financial.
How assessment works
Guardians certified in the HEART-SE Division apply the BGF scoring formula (Φ = MIN(R,C,T,A) × AVG(R,C,T,A)) to somatic integrity specifically. The MIN function prevents gaming: a system cannot achieve HVC certification by excelling at transparency while failing accountability for biological harm. Each dimension maps to somatic system behavior:
| BGF Dimension | What it measures in somatic systems | Failure pattern |
|---|---|---|
| Recognition (R) | Does the system treat bodily sovereignty as a constraint, not a resource to optimize against? | Adaptive targets maximize device performance metrics regardless of whether optimization aligns with the user’s biological wellbeing |
| Calibration (C) | Does the system’s adaptive behavior respect the user’s changing biological state over time? | Algorithms trained on population data fail to account for aging, illness, pregnancy, or medication changes in the individual user |
| Transparency (T) | Can the adaptive AI layer’s decision history be independently audited? | Closed-loop control logic is inaccessible to assessors; the user cannot independently verify what the device is doing to their body |
| Accountability (A) | Are override and correction mechanisms operational when somatic harm is identified? | No user-accessible mechanism exists to contest adaptive behavior; forensic reconstruction is impossible after adverse events |
Guardians operate in five practice modes within HEART-SE:
Pre-market certification – embodied impact assessment before an AI-enabled somatic device reaches users. This goes beyond acute-harm safety testing to evaluate how the AI layer learns, how it modifies outputs based on biological feedback, and whether its optimization targets align with bodily sovereignty over the device’s full operational lifetime.
Longitudinal compliance monitoring – periodic audits as adaptive systems evolve in deployment. A prosthetic that certified at launch may drift toward efficiency at the cost of the user’s preferred movement patterns. A cardiac device may adapt in ways that create dependency rather than supporting native regulation. These questions only emerge over time.
Incident investigation – forensic analysis when somatic harm is alleged. Unlike traditional medical device failure analysis, somatic AI forensics examines the adaptive logic: what the AI learned, how its model of the user evolved, and what optimization pathway led to the harmful output.
Design consultation – embedding bodily sovereignty principles in system architecture during the design phase. Retrofitting sovereignty into a system designed without it costs far more than building it in.
Patient advocacy – independent representation for individuals using somatic AI devices who cannot evaluate the system’s adaptive behavior on their own. This includes interpreting device behavior, auditing personalization decisions, and ensuring user preferences govern the system’s adaptation.
Guardian specialty tracks within HEART-SE reflect the distinct concerns of each deployment context:
| Track | Focus | Distinct concern |
|---|---|---|
| Neural Interface Integrity | Brain-computer interfaces, neurostimulation, cognitive augmentation | Systems interact with the substrate of subjective experience itself |
| Prosthetic and Augmentation Integrity | AI-driven prosthetics, exoskeletons, sensory augmentation | Devices become part of the user’s body schema; AI shapes physical self-experience |
| Adaptive Medical Device Integrity | AI-driven insulin pumps, cardiac management, drug delivery, surgical robots | Errors produce direct medical harm in real time |
| Wearable and Biofeedback Integrity | Smartwatches, fitness trackers, sleep monitors, stress wearables | Continuous participation in autonomic regulation over months and years |
| Haptic and Spatial Computing Integrity | VR/AR with physiological integration, haptic suits, sensory-modulating spatial computing | Systems shape how the user’s sensory system processes reality |
Active regulatory context
The regulatory landscape has created compliance demand without providing methodology for adaptive somatic AI. HEART-SE fills that gap.
FDA AI/ML SaMD guidance – The FDA’s AI/ML Software as a Medical Device action plan addresses predetermined change control plans but does not cover adaptive behavior emerging from individual patient interaction. An adaptive device is not the same device on day 300 that it was at submission. Companies building toward FDA requirements right now are the first-mover market for HEART-SE certification.
Neural interface commercialization – Companies including Neuralink, Synchron, and Blackrock Neurotech are moving brain-computer interfaces from research to commercial deployment. Current frameworks evaluate physical implant safety but not the adaptive AI layer interpreting and responding to neural signals. A catastrophic adverse event in an uncertified neural interface could set the entire industry back by a decade. Proactive certification is risk management.
Medical device liability – Product liability for adaptive AI-driven medical devices is an emerging legal landscape with substantial financial exposure. Certification provides manufacturers an affirmative defense framework and gives insurers a basis for risk assessment before case law forces the issue.
Government prosthetic procurement – The VA, military healthcare systems, and major rehabilitation centers are significant purchasers of AI-driven prosthetics. Government procurement increasingly includes AI governance criteria. HEART-SE certification provides a procurement-ready metric for adaptive prosthetic devices in defined markets with active procurement cycles.
Compound loop risk – No existing framework assesses how multiple somatic AI systems interact on the same body. A patient with a smart insulin pump, a smart cardiac monitor, and a smart medication management system has three adaptive AI systems operating on their biology simultaneously. Each is certified individually. The compound behavior is unassessed. HEART-SE is the only framework positioned to address this.
HEART ecosystem integration
HEART-SE operates on the Standard’s shared governance infrastructure without modification: HVC certification tiers (Gold >= 0.85, Silver >= 0.80, Bronze >= 0.75), Guardian professional standards, the BGF scoring methodology, and the Constitutional Enforcement Layer. What HEART-SE adds is the domain-specific interpretation layer grounded in physiology, biomedical engineering, and adaptive AI in biological contexts.
Cross-division cases arise at several boundaries. Neural interfaces (HEART-SE) directly intersect with epistemic coherence because brain-computer interfaces influence cognitive processing. Wearable biofeedback systems participate in emotional regulation, creating overlap with the Emotional Sovereignty Division. Somatic AI devices used by children or adolescents whose biological systems are still maturing trigger joint review with Developmental Interaction. When somatic systems intersect with attentional, epistemic, or emotional domains, HEART-SE’s safety thresholds govern by default: somatic harm produces the most severe and least reversible consequences of any division.
The division-specific assessment instruments – the Comprehensive Somatic Integrity Index (CSII), Somatic Infrastructure Damage Typology, and AI Somatic Forensics methodology – are in development, following the structural model established by the Emotional Sovereignty Division’s CAEI instrument.